A significant relationship between mercury exposure from dental amalgams and urinary porphyrins: a further assessment of the Casa Pia children’s dental amalgam trial
- 386 Downloads
Previous studies noted specific changes in urinary porphyrin excretion patterns associated with exposure to mercury (Hg) in animals and humans. In our study, urinary porphyrin concentrations were examined in normal children 8–18 years-old from a reanalysis of data provided from a randomized, prospective clinical trial that was designed to evaluate the potential health consequences of prolonged exposure to Hg from dental amalgam fillings (the parent study). Our analysis examined dose-dependent correlations between increasing Hg exposure from dental amalgams and urinary porphyrins utilizing statistical models with adjustments for the baseline level (i.e. study year 1) of the following variables: urinary Hg, each urinary porphyrin measure, gender, race, and the level of lead (Pb) in each subject’s blood. Significant dose-dependent correlations between cumulative exposure to Hg from dental amalgams and urinary porphyrins associated with Hg body-burden (pentacarboxyporphyrin, precoproporphyrin, and coproporphyrin) were observed. Overall, 5–10% increases in Hg-associated porphyrins for subjects receiving an average number of dental amalgam fillings in comparison to subjects receiving only composite fillings were observed over the 8-year course of the study. In contrast, no significant correlations were observed between cumulative exposure to Hg from dental amalgams and urinary porphyrins not associated with Hg body-burden (uroporphyrin, heptacarboxyporphyrin, and hexacarboxyporphyrin). In conclusion, our study, in contrast to the no-effect results published from the parent study, further establishes the sensitivity and specificity of specific urinary porphyrins as a biomarker for low-level Hg body-burden, and also reveals that dental amalgams are a significant chronic contributor to Hg body-burden.
KeywordsBody burden Dental amalgam Mercury Porphyrin
This study received funding from the non-profit International Academy of Oral Medicine and Toxicology (IAOMT), the non-profit Institute of Chronic Illnesses, Inc., and the non-profit CoMeD, Inc. None of the organizations providing financial support for the present study had any influence on data analyses or conclusions. We wish to thank Lisa Sykes for reviewing the present manuscript.
Conflict of interest
None of the other authors has any conflicts of interest concerning the present study.
- Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Asposhian MM, Dart RC, Diaz Gama JH, Echeveria D, Woods JS, Aposhian H (1995) Sodium 2, 3-dimercaptopropane-1-sulfonate challenge test for mercury in humans II: urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther 272(1):264–274PubMedGoogle Scholar
- Kern JK, Geier DA, Adams JB, Geier MR (2010a) A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder. Biometals Jan 9, 2010 [Epub ahead of print]Google Scholar
- Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR (2010b) Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins. Pediatr Int Jul 4, 2010 [Epub ahead of print]Google Scholar
- Kern JK, Geier DA, Ayzac F, Adams JB, Garver CR, Mehta JA, Geier MR (2010c) Toxicity biomarkers among US children in comparison with French children: A prospective blinded study of urinary porphyrins. Toxicol Environ Chem Google Scholar
- Woods JS, Martin MD, Leroux BG, DeRouen TA, Leitão JG, Bernardo MF, Luis HS, Simmonds PL, Kushleika JV, Huang Y (2007) The contribution of dental amalgam to urinary mercury excretion in children. Environ Health Perpsect 115(10):1527–1531Google Scholar
- Woods JS, Martin MD, Leroux BG, DeRouen TA, Bernardo MF, Luis HS, Leitão JG, Simmonds PL, Echeverria D, Rue TC (2009) Urinary porphyrin excretion in children with mercury amalgam treatment: findings from the Casa Pia Children’s Dental Amalgam Trial. J Toxicol Environ Health A 72(14):891–896PubMedCrossRefGoogle Scholar